BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Losurdo G, Salvatore D'Abramo F, Indellicati G, Lillo C, Ierardi E, Di Leo A. The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders. Int J Mol Sci 2020;21:E3531. [PMID: 32429454 DOI: 10.3390/ijms21103531] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Zhang L, Hou X. Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 2021;15:1385-99. [PMID: 34767484 DOI: 10.1080/17474124.2021.2005579] [Reference Citation Analysis]
2 Nyholm D, Hellström PM. Effects of Helicobacter pylori on Levodopa Pharmacokinetics. J Parkinsons Dis 2021;11:61-9. [PMID: 33164946 DOI: 10.3233/JPD-202298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sanjeevi R, Jamwal KD, Dhar Chowdhury S, Ramadass B, Gayathri R, Dutta AK, Joseph Joseph A, Ramakrishna BS, Chacko A. Assessment of small intestinal bacterial overgrowth in chronic pancreatitis patients using jejunal aspirate culture and glucose hydrogen breath test. Scand J Gastroenterol 2021;56:588-93. [PMID: 33730978 DOI: 10.1080/00365521.2021.1900383] [Reference Citation Analysis]
4 Menozzi E, Macnaughtan J, Schapira AHV. The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance. Ann Med 2021;53:611-25. [PMID: 33860738 DOI: 10.1080/07853890.2021.1890330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Milošević M, Arsić A, Cvetković Z, Vučić V. Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition. Front Nutr 2021;8:688086. [PMID: 34422879 DOI: 10.3389/fnut.2021.688086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fonseca Cabral G, Schaan AP, Cavalcante GC, Sena-Dos-Santos C, de Souza TP, Souza Port's NM, Dos Santos Pinheiro JA, Ribeiro-Dos-Santos Â, Vidal AF. Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson's Disease. Int J Mol Sci 2021;22:9839. [PMID: 34576000 DOI: 10.3390/ijms22189839] [Reference Citation Analysis]
7 Di Tommaso N, Gasbarrini A, Ponziani FR. Intestinal Barrier in Human Health and Disease. Int J Environ Res Public Health 2021;18:12836. [PMID: 34886561 DOI: 10.3390/ijerph182312836] [Reference Citation Analysis]
8 Kucheryavyy YA, Andreev DN, Maev IV. [Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis]. Ter Arkh 2020;92:53-8. [PMID: 33720574 DOI: 10.26442/00403660.2020.12.200433] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Riccio P, Rossano R. The human gut microbiota is neither an organ nor a commensal. FEBS Lett 2020;594:3262-71. [PMID: 33011965 DOI: 10.1002/1873-3468.13946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]